Nelotanserin ( DrugBank: Nelotanserin )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02871427 (ClinicalTrials.gov)	October 20, 2016	15/8/2016	Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder	An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder	Lewy Body Dementia;Dementia With Lewy Bodies;Parkinson's Disease Dementia;Visual Hallucinations;REM Sleep Behavior Disorder	Drug: Nelotanserin	Axovant Sciences Ltd.	NULL	Terminated	50 Years	N/A	All	80	Phase 2	United States
2	NCT02708186 (ClinicalTrials.gov)	March 2016	10/3/2016	Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)	A Phase 2, Double-blind, Randomized, Placebo-controlled Study of Nelotanserin Versus Placebo in Subjects With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) Who Have REM Sleep Behavior Disorder (RBD)	Dementia With Lewy Bodies;REM Sleep Behavior Disorder;Parkinson's Disease Dementia	Drug: Nelotanserin;Drug: Placebo	Axovant Sciences Ltd.	NULL	Completed	50 Years	N/A	All	34	Phase 2	United States